Young women with breast cancer and Leah Lederman Lecture: This webinar aims to teach healthcare professionals, both at a primary and specialist level a multidisciplinary approach towards managing young women with breast cancer, both in the early and advanced setting.
Date and time: Mon 21 Jun 2021 from 9:30am to 4:30pm
Register here
Join us for a unique opportunity to look at the multifaceted approach towards young women with breast cancer, looking at the latest data from world-leading experts both at the treatment and support of women in these positions. This session will provide a multidisciplinary approach as well as an evaluation of the science and latest advances in the interpretation of this data.
In an interactive setting, we will be focusing on the latest updates on the scientific, clinical and psychosocial aspects of breast cancer in young women and the multidisciplinary management of the disease.
This webinar is for healthcare professionals only.
Learning objectives for the participants:
- Management of advanced breast cancer with a particular emphasis on young women
- Understanding the hereditary risk factors associated with breast cancer and have use of the NHS directory influences management
- Fertility preservation procedures and pregnancy outcomes in women who have had previous breast cancer
- Conference updates in breast cancer management with particular emphasis on the management of young women with breast cancer
- Advising on lifestyle changes and mental health for women who have been diagnosed with breast cancer
A CPD certificate with 6 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed
We would like to thank our sponsors AstraZeneca & Daiichi Sankyo, Novartis, Pierre-Fabre Ltd and Roche for their support of this webinar. Promotional symposium organised by Daiichi Sakyo and AstraZeneca is intended for Healthcare professionals.
Please note that the scientific programme and content has not been influenced in any way by the sponsors.
Agenda
Welcome and Introduction
Dr Marina Parton and Dr Bhawna Sirohi
Session one
Dr Bhawna Sirohi
Patient speaker
The Leah Ledermann lecture – Managing advanced breast cancer in young women
Dr Fatima Cardoso, Director, Breast Unit, Champalimaud Clinical Centre, President ABC Global Alliance, Lisbon, Portugal
Panel discussion
Break and sponsor presentation
Kisqali and the treatment of pre-menopausal women – presentation by Novartis, given by Dr Mark Tuthill, Consultant Medical Oncologist, The Churchill Hospital, Oxford
Session two
Chair: Mr Henry Cain
Hereditary Breast cancer risk- what we now know
Dr Helen Hanson, Consultant in Cancer Geneticist, St George’s, University Hospital NHS Foundation Trust
The NHS genetics directory in the breast clinic
Dr Zoe Kemp, Consultant Geneticist, Royal Marsden Hospital
Panel discussion
Chair: Dr Susie Stanway
Fertility and pregnancy after breast cancer – real world data
Dr Yuliya Kopeika, Consultant Gynaecologist, Subspecialist in Reproductive medicine Guy’s and St Thomas’ Hospital NHS Foundation Trust
Panel discussion
Lunch break and Daiichi Sankyo and AstraZeneca sponsored symposium
Redefining expectations in third-line HER2+ metastatic breast cancer (mBC); given by Dr Alicia Okines, Consultant Medical Oncologist, from The Royal Marsden hospital.
Promotional symposium organised by Daiichi Sankyo and AstraZeneca is intended for HCPs only. Daiichi Sankyo and AstraZeneca have had no other involvement into the other aspects of this meeting
Session four
Chair: Dr Marina Parton
Conference reports ; whats new for young women with breast cancer
Dr Shaheenah Dawood, Head of Medical Oncology, Head of the Breast Cancer Program, Dubai, UAE
The potential of PARP inhibitors in breast cancer
Professor Andrew Tutt, Head of Division, Breast Cancer Research, The Institute of Cancer Research, Director of the Breast Cancer Now Research Centre, Institute of Cancer Research, and Breast Cancer Now Research Unit, Kings College London, Clinician Scientist, Consultant Clinical Oncologist in Breast Cancer
Panel discussion
Break and sponsor presentation
Addressing Health Disparities in Breast Cancer Clinical Research – presentation by Roche, given by Ed Merivale & Howard Turner
Session five
Chair: Dr Richard Simcock
Excercsing and breast cancer
Dr Caroline Wilson, Consultant Medical Oncologist Weston Park Cancer Centre, Sheffield, Honorary Clinical Senior Lecturer UoS and Dr Catherine Harper-Wynne, Consultant Medical Oncologist and Honorary Senior Lecturer University of Kent
Diet and breast cancer
Dr Clare Shaw, Consultant Dietician, The Royal Marsden NHS Foundation Trust
Cognitive impairment during cancer treatment
Dr Stuart Anderson, Consultant Neuropsychologist, Independent Practice and Health and Social Care Directorate, States of Guernsey
The fear of cancer recurrence
Mr Ben Smith, CONCERT Co-Deputy Director (Policy and Practice) Conjoint Senior Lecturer, UNSW Sydney
Panel discussion
Closing remarks
The origins of the Royal Society of Medicine date back to the 18th century when, throughout Europe, medical societies began to be founded with the object of bringing together physicians and surgeons.
- The Golden Age of Melancholy, Royal Society of Medicine Library - 16th January 2023
- Health experts fear impact of deteriorating hostile environment - 26th February 2022
- Update on cancer genetics, epigenetics and resulting therapeutics - 11th January 2022
